Abstract:In Reply Thank you for these comments. We would like to respond to the comments as follows: In our study, the duration of OME were 1 to 12 months with an average data of 19.33 weeks, as described in Participants in MATERIALS AND METHODS. We mentioned 78.9% of participants experienced an URI before OME, just implying the possible etiology. OME after URI usually resolves spontaneously within 2 weeks for older children and adults. Also, the various durations did not influence the comparative results between groups basing on randomization. The therapeutic efficacy evaluation was performed weekly by pneumatic otoscopy and scoring clinical symptoms, which were carried out before ITS operation. It was true that two times of face-to-face follow-ups after the end of ITS was insufficient, which certainly made the design imperfect. Nevertheless, we had to decrease the times of re-examination after ITS because of the inconvenience for most participants who were from other cities, and the following follow-up mainly relied on telephone inquiry effectively. The data from telephone follow-up were also included to perform survival analysis in Figure 2. In our study, we included subjects by pneumatic otoscopy (the golden diagnosis criteria). Also, during the administration of ITS and after treatment, besides symptoms evaluation and pure tone test, pneumatic otoscopy was an important indicator for assessing therapeutic efficacy. In Figure 2, “week 0” represented the beginning of evaluation of therapeutic efficacy, which was performed 1 week after the first ITS and exactly before the second ITS. The data 100% in all groups meant patients still had OME manifestation and were willing to receive further ITS at that follow-up, or they were totally cured. The ITS treatment varied 1 to 12 times in the three groups. The “survival event” defined in the Kaplan-Meier survival curves was a status of either the patients had been cured without recurrence in the follow-up or the patients were unhealed but sufficiently satisfied with ITS administration and willing to receive more. Of course, it should be clearer if we use “week 1” as the beginning of the x axis. Regarding the long-term preventive effect of ITS on the remission of OME, both the Bud and Dex had good effect. Once OME recovered, the recurrence was unusual in adults and older children. Therefore, the effect that remained after 25 weeks was understandable. Honestly, we appreciate the valuable comments by Dr. Lee. It was extremely helpful in our further practice. Ping An, M.D. Yu Zhao, Ph.D., M.D. Fengling Yang, M.D. Department of Otolaryngology Head and Neck Surgery West China Hospital, Sichuan University, Chengdu Sichuan, China [email protected]

REPLY TO DONG-HEE LEE'S LETTER TO THE EDITOR RE: YANG F, ZHAO Y, AN P, ET AL. LONGITUDINAL RESULTS OF INTRATYMPANIC INJECTION OF BUDESONIDE FOR OTITIS MEDIA WITH EFFUSION IN CHILDREN OVER 12 YEARS AND ADULTS

Reply to Dong-Hee Lee's Letter to the Editor RE: Yang F, Zhao Y, An P, et al. Longitudinal Results of Intratympanic Injection of Budesonide for Otitis Media With Effusion in Children Over 12 Years and Adults. Otol Neurotol 2014;35&colon;629-34.

The long-term efficacy and safety of balloon dilation eustachian tuboplasty combined with tympanostomy tube insertion for patients with otitis media with effusion: study protocol for a prospective randomized controlled trial

Predictors of Conservative Treatment Outcomes for Adult Otitis Media with Effusion

[Preliminary Study on Intratympanic Dexamethasone Injection for Management of Patients with Profound Sudden Hearing Loss].

A Short Term Study on the Efficacies of Intratympanic Prednisolone and Dexamethasone Injection for Subjective Tinnitus

A multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of Chinese patients with blepharokeratoconjunctivitis.

A Three-Month Non-Interventional Study of Asthma Treatment with Budesonide/Formoterol

[The effect of intratympanic dexamethasone or methylprednisolone on treatment of sudden sensorineural hearing loss].

[Different treatment methods and efficacy analysis of otitis media with effusion in children with different hearing loss]

Treatment of Subjective Tinnitus: A Comparative Clinical Study of Intratympanic Steroid Injection Vs. Oral Carbamazepine

Efficacy and safety of ambroxol hydrochloride in the treatment of secretory otitis media: a systematic review and meta-analysis

Long-term efficacy of dexamethasone treatment via tympanic antrum catheterization for intractable Meniere's disease

Analysis of Therapeutic Options for Noise-Induced Hearing Loss: Retroauricular Injection of Methylprednisolone Sodium Succinate Combined with Hyperbaric Oxygenation

Efficacy of intratympanic dexamethasone combined with prednisone on idiopathic sudden sensorineural hearing loss

Efficacy of Various Corticosteroid Treatment Modalities for the Initial Treatment of Idiopathic Sudden Hearing Loss: A Prospective Randomized Controlled Trial

Effect of Glucocorticoid on Subacute Otitis Media with Effusion and Its Affection on TNF-α、IL-10 in Blood Plasma in Adults

Efficacy of middle ear therapy device on chronic otitis media with effusion in children

Comparative of the treatment effects in adult moderate to severe allergic rhinitis by Loratadine with Budesonide nasal spray or Triamcinolone Acetonide nasal spray

Inhaled Budesonide vis-à-vis Inhaled Mometasone in Chinese Children with Mild Persistent Asthma: A Single-Center, Retrospective Study

[Observation on the Efficacy of Eustachian Tube Dilation Hormone under the Guidance of Endoscope in the Treatment of Sudden Deafness].